News
Enter your email address to get Core One Labs News Alerts.
Company News
Core One Labs Files Application to List its Common Shares on NASDAQ
March 20, 2021
Vancouver, British Columbia, Canada – March 20, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (“Core One” or the “Company”) is pleased to announce that it has filed...
Read more
Company News
Core One Labs to Commence Trading in the US on OTC Pink Market
March 14, 2021
Vancouver, British Columbia, Canada – March 14, 2021 – Core One Labs Inc. (CSE: COOL), (OTC Pink: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) a research and...
Read more
Company News
Psychedelic Expert Core One Labs Reports Milestone Acquisition The Developer of Psychedelic Treatments Enters the Telehealth Space with Access to Close to 80,000 Clinic Patients
March 12, 2021
Vancouver, British Columbia, Canada – March 12, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
Core One Labs In Collaboration with KICT To Explore DMT Assisted Psychotherapy
March 09, 2021
Vancouver, British Columbia, Canada – March 9, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
Core One Labs’ Subsidiary Vocan to Work with Former Canopy CEO Mr. Marcelo Galvão to License Biosynthesized Psilocybin in Brazil
March 04, 2021
Vancouver, British Columbia, Canada – March 4, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
Core One Labs Initiates First Strain Production for Biosynthetic Psilocybin
February 26, 2021
Vancouver, British Columbia, Canada – February 26, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”) a biotechnology research...
Read more